PMID: Front Oncol. 2019 ;9:501. Epub 2019 Jun 14. PMID: 31259152 Abstract Title: Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88. Abstract: Paclitaxel (PTX) is widely used as a front-line chemotherapy for breast cancer treatment. However, its clinical applications are limited by the development of chemoresistance. The objective of …
Continue reading “Ursolic acid reverses the chemoresistance of breast cancer cells to paclitaxel.”